Cargando…
Time to improve statin prescription guidelines in low-risk patients?
BACKGROUND: The challenge of the primary prevention of cardiovascular disease (CVD) is to identify patients who would benefit from treatment with statins. Statins are currently prescribed to many patients, even those at a low 10-year risk of CVD. These latter patients may not be eligible for statins...
Autores principales: | Balder, Jan W, de Vries, Jeroen K, Mulder, Douwe J, Kamphuisen, Pieter W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476184/ https://www.ncbi.nlm.nih.gov/pubmed/28429651 http://dx.doi.org/10.1177/2047487317698585 |
Ejemplares similares
-
Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy
por: van Zoest, Rosan A, et al.
Publicado: (2017) -
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors
por: Lechner, Katharina, et al.
Publicado: (2019) -
Hypertensive disorders of pregnancy and cardiometabolic outcomes in
childhood: A systematic review
por: Jansen, Maria AC, et al.
Publicado: (2019) -
Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study
por: Byambasukh, Oyuntugs, et al.
Publicado: (2019) -
Relations between the residential fast-food environment and the individual risk of cardiovascular diseases in The Netherlands: A nationwide follow-up study
por: Poelman, Maartje, et al.
Publicado: (2018)